Bravo Vergel, Y; Hawkins, NS; Claxton, K; Asseburg, C; Palmer, S; Woolacott, N; Bruce, IN; Sculpher, MJ; (2007) The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis. Rheumatology (Oxford, England), 46. pp. 1729-35. ISSN 1462-0324 DOI: https://doi.org/10.1093/rheumatology/kem221 Full text not available from this repository.

Woolacott, N; Bravo Vergel, Y; Hawkins, N; Kainth, A; Khadjesari, Z; Misso, K; Light, K; Asseburg, C; Palmer, S; Claxton, K; +3 more... Bruce, I; Sculpher, M; Riemsma, R; (2006) Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation. Health technology assessment (Winchester, England), 10. iii-iv, xiii-xvi, 1-239. ISSN 1366-5278 https://researchonline.lshtm.ac.uk/id/eprint/2534859